-
UroGen Pharma's (URGN) "Buy" Rating Reaffirmed at HC Wainwright
来源: Buzz FX / 15 10月 2024 09:47:12 America/New_York
UroGen Pharma's (URGN) "Buy" Rating Reaffirmed at HC Wainwright Written by MarketBeat October 15, 2024 Share Link copied to clipboard. UroGen Pharma ( NASDAQ:URGN - Get Free Report ) 's stock had its "buy" rating reaffirmed by investment an
Read more...